Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Ketorolac vs Intranasal Dexmedetomidine for Postoperative Analgesia in Pediatric Myringotomy
NCT03742180Withdrawn
- Sponsor
- Mansoura University
- Start
- Jan 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative pain and agitation (2 arms), sponsored by Mansoura University. Primary endpoint: duration of analgesia at 24 hours. Planned start Jan 2018; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painagitation
Beyond the preview
Go deeper on NCT03742180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03742180.